Back to search
FDAFDA · Food and drugs·Recall number Z-2059-2018

RX Imola (RX4900) For Professional Use for the quantitative in vitro determination of various clinical chemistry tests.

Published June 13, 2018 · Recall initiated: May 4, 2018

Summary

FDA records medical device Class II recall Z-2059-2018, published June 13, 2018 and initiated May 4, 2018. Recalling firm: Randox Laboratories; Status: Terminated; Reported quantity: 41 analyzers; Lot: GTIN 05055273206104. All serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Abnormal premature termination of the software could affect the use of the analyser when running patient samples. The impact being a delay in reporting test results.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories
Distributor
US Distribution including Puerto Rico and the state of : West Virginia.
Lot
GTIN 05055273206104. All serial numbers.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was RX Imola (RX4900) For Professional Use for the quantitative in vitro determination of various clinical chemistry tests. recalled?

Yes. FDA published recall Z-2059-2018 on June 13, 2018. Reported hazard: Abnormal premature termination of the software could affect the use of the analyser when running patient samples. The impact being a delay in reporting test results.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit